A neonate with mucolipidosis II and transient secondary hyperparathyroidism.

J Pediatr Endocrinol Metab

University of Miami Miller School of Medicine, Division of Pediatric Endocrinology, 1601 NW 12th Avenue, Suite 3044A, Miami, FL 33136-1015, USA, Phone: +1-305-243-5707, Fax: +1-305-243-6309.

Published: December 2019

Background Mucolipidosis II α/β (ML II) is an autosomal recessive disease associated with the abnormality of lysosomal enzyme trafficking. Case presentation We present an unusual patient with: (a) marked skeletal anomalies with secondary hyperparathyroidism; (b) serum intact parathyroid hormone level normalized by 7 weeks but abnormally elevated serum alkaline phosphate persisted; and (c) two mutations identified in the GNPTAB gene. One mutation, c.3503_3504delTC, is the most common mutation in ML II. However, the second mutation, c.2896delA, is a rare mutation for which clinical presentation has not been described previously.

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem-2019-0162DOI Listing

Publication Analysis

Top Keywords

secondary hyperparathyroidism
8
neonate mucolipidosis
4
mucolipidosis transient
4
transient secondary
4
hyperparathyroidism background
4
background mucolipidosis
4
mucolipidosis α/β
4
α/β autosomal
4
autosomal recessive
4
recessive disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!